Bioatla Stock Performance

BCAB Stock  USD 0.31  0  0.32%   
The firm shows a Beta (market volatility) of -2.55, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Bioatla are expected to decrease by larger amounts. On the other hand, during market turmoil, Bioatla is expected to outperform it. At this point, Bioatla has a negative expected return of -0.91%. Please make sure to confirm Bioatla's total risk alpha, skewness, day median price, as well as the relationship between the maximum drawdown and daily balance of power , to decide if Bioatla performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Bioatla has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2026. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
1
Disposition of 12530 shares by Sievers Eric of Bioatla at 0.46 subject to Rule 16b-3
11/11/2025
2
BioAtla Q3 2025 Earnings Call Transcript
11/13/2025
3
Disposition of 6347 shares by Jay Short of Bioatla at 0.409 subject to Rule 16b-3
11/14/2025
4
BioAtla Inc. stock outlook for YEAR - 2025 Breakouts Breakdowns Safe Capital Allocation Plans - newser.com
11/18/2025
5
BioAtla Enters into Agreements for up to 22.5 Million Flexible Financing
11/21/2025
6
Disposition of 1566 shares by Christian Vasquez of Bioatla at 0.904 subject to Rule 16b-3
11/28/2025
7
How rising interest rates impact BioAtla Inc. stock - 2025 Bull vs Bear Weekly Momentum Stock Picks - DonanmHaber
12/19/2025
8
BioAtla and GATC Health Announce a 40 Million Special Purpose Vehicle Transaction to Advance Ozuriftamab Vedotin into a Registrational Trial for 2L Oropharyngea...
12/31/2025
9
Why BioAtla Inc. stock remains resilient - July 2025 Gainers Real-Time Buy Signal Notifications - ulpravda.ru
01/08/2026
10
BioAtla faces Nasdaq delisting over share price rule - MSN
01/14/2026
11
12 Health Care Stocks Moving In Tuesdays Pre-Market Session - Benzinga
01/27/2026

Bioatla Relative Risk vs. Return Landscape

If you would invest  70.00  in Bioatla on October 31, 2025 and sell it today you would lose (38.90) from holding Bioatla or give up 55.57% of portfolio value over 90 days. Bioatla is currently does not generate positive expected returns and assumes 9.1768% risk (volatility on return distribution) over the 90 days horizon. In different words, 82% of stocks are less volatile than Bioatla, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Bioatla is expected to under-perform the market. In addition to that, the company is 12.16 times more volatile than its market benchmark. It trades about -0.1 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.07 per unit of volatility.

Bioatla Target Price Odds to finish over Current Price

The tendency of Bioatla Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.31 90 days 0.31 
under 95
Based on a normal probability distribution, the odds of Bioatla to move above the current price in 90 days from now is under 95 (This Bioatla probability density function shows the probability of Bioatla Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Bioatla has a beta of -2.55 suggesting as returns on its benchmark rise, returns on holding Bioatla are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Bioatla is expected to outperform its benchmark. Additionally Bioatla has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Bioatla Price Density   
       Price  

Predictive Modules for Bioatla

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bioatla. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.010.289.46
Details
Intrinsic
Valuation
LowRealHigh
0.142.7311.91
Details
Naive
Forecast
LowNextHigh
0.010.399.57
Details
4 Analysts
Consensus
LowTargetHigh
9.1010.0011.10
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Bioatla. Your research has to be compared to or analyzed against Bioatla's peers to derive any actionable benefits. When done correctly, Bioatla's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Bioatla.

Bioatla Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Bioatla is not an exception. The market had few large corrections towards the Bioatla's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Bioatla, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Bioatla within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.72
β
Beta against Dow Jones-2.55
σ
Overall volatility
0.22
Ir
Information ratio -0.11

Bioatla Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Bioatla for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Bioatla can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Bioatla generated a negative expected return over the last 90 days
Bioatla has high historical volatility and very poor performance
Bioatla has some characteristics of a very speculative penny stock
Bioatla has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 11 M. Net Loss for the year was (69.78 M) with loss before overhead, payroll, taxes, and interest of (46.73 M).
Bioatla currently holds about 178.12 M in cash with (71.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.77, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Latest headline from news.google.com: 12 Health Care Stocks Moving In Tuesdays Pre-Market Session - Benzinga

Bioatla Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Bioatla Stock often depends not only on the future outlook of the current and potential Bioatla's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bioatla's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding48.6 M
Cash And Short Term Investments49 M

Bioatla Fundamentals Growth

Bioatla Stock prices reflect investors' perceptions of the future prospects and financial health of Bioatla, and Bioatla fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bioatla Stock performance.

About Bioatla Performance

By analyzing Bioatla's fundamental ratios, stakeholders can gain valuable insights into Bioatla's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Bioatla has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bioatla has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Return On Tangible Assets(1.20)(1.26)
Return On Capital Employed(2.24)(2.13)
Return On Assets(1.20)(1.26)
Return On Equity(5.63)(5.34)

Things to note about Bioatla performance evaluation

Checking the ongoing alerts about Bioatla for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bioatla help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Bioatla generated a negative expected return over the last 90 days
Bioatla has high historical volatility and very poor performance
Bioatla has some characteristics of a very speculative penny stock
Bioatla has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 11 M. Net Loss for the year was (69.78 M) with loss before overhead, payroll, taxes, and interest of (46.73 M).
Bioatla currently holds about 178.12 M in cash with (71.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.77, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Latest headline from news.google.com: 12 Health Care Stocks Moving In Tuesdays Pre-Market Session - Benzinga
Evaluating Bioatla's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Bioatla's stock performance include:
  • Analyzing Bioatla's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bioatla's stock is overvalued or undervalued compared to its peers.
  • Examining Bioatla's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Bioatla's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bioatla's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Bioatla's stock. These opinions can provide insight into Bioatla's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Bioatla's stock performance is not an exact science, and many factors can impact Bioatla's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Bioatla Stock analysis

When running Bioatla's price analysis, check to measure Bioatla's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioatla is operating at the current time. Most of Bioatla's value examination focuses on studying past and present price action to predict the probability of Bioatla's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioatla's price. Additionally, you may evaluate how the addition of Bioatla to your portfolios can decrease your overall portfolio volatility.
CEOs Directory
Screen CEOs from public companies around the world
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance